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The biomaterials group at CTB has developed a new technique for the 
biofunctionalization of a wide range of materials with primary amines. Numerous 
proteins and other biomolecules were covalently bound to the amine groups using the 
EDC/NHS chemistry as cross-linking agents. The aim of this work is to study material 
bio functionalization with other crosslinking agents; Sulfhydryl group will be studied as 
a reversible way of crosslinking proteins to a surface through disulfide bond formation. 
We hypothesize that this molecules will yield better material-cell interactions and 
improve the bioactivity of biocompatible materials such as silicon, titanium and glass. 
Complementarily the protein adsorption process onto a solid surface will be investigated 
to characterize it in both static and dynamic conditions.  
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1.1. Motivation of work 
Protein adsorption on biomaterials is of great interest in the biomedical industry both for 
diagnostics (bioimaging and affinity-detection techniques) and therapeutics (implants, 
surgical and laboratory material…) as it enhances biological performance, affinity and 
biocompatibility.  
This protein adsorption process is not well-characterized nor understood, and as critical 
as it is in biomaterial outcome and success of the application, it should be thoroughly 
studied. 
Thiol groups arouses great interest in bioconjugation research as it opens promising 
possibilities for creating reversible interactions with proteins and other biomolecules. 
Some techniques have been previously reported in the literature for attaching thiol groups 
on solid surfaces such as mercapto-silane self-assembly on silaceous and metal surfaces, 
self-assembly on gold using thiol groups on both ends of the conjugating molecule, 
immobilization of thiol containing conjugators on otherwise functionalized surfaces or 
continuous phase glow discharge polymerization using thiol containing monomers. Each 
of these techniques have their own drawbacks, being some of them complicated 
processing, substrate specificity or the loss of thiol group functionality [21]. 
1.2. Goals 
In this work a new reversible three-step biofunctionalization method for silicon thin films 
is developed based on the exposure of thiol groups on the solid surface that will later on 
interact with a protein via disulfide bond formation. Since it relies on disulfide bond 
formation, the protein adsorption or immobilization (depending on the application) can 
be reverted with commonly used disulfide reducing agents such as DTT.  
The efficiency of this crosslinking scheme is intended to be proved by using the enzyme 
lactate dehydrogenase as model. As a first step in this experimental program, the protein 
adsorption process is analyzed so that its interaction with the substrate may be understood. 
Both static and dynamic adsorption conditions are characterized through enzymatic 
assays. Also, a mathematical model based on the experimental results is used for further 
unraveling of protein adsorption kinetics. LDH is used as the protein model since the 
reaction it catalyzes can be easily followed by spectrophotometry measurements. 
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2. STATE OF THE ART 
2.1. Current situation 
2.1.1. Biomaterials, its role in the biomedical industry and the importance of 
biofunctionalization 
“A biomaterial can be defined as a material intended to interface with biological systems 
to evaluate, treat, augment or replace any tissue, organ or function of the body”. 
*(Consensus definition, 2nd Biomaterials Consensus Conference, 1992, Chester, UK). According with 
this definition, the range of materials and applications that could be considered is very 
broad: the several types of implants that serve to replace a diseased or non-working part 
of the body or to enhance or correct its function, materials used to aid in the process of 
healing as in the case of sutures, to act as drug delivery systems (hydrogels, NPs…), as 
scaffolds for tissue engineering and of course the many applications in diagnosis acting 
as biosensors, or for laboratory material [3][13][15]. 
Depending on the application, one type of material or another will be selected (metals, 
polymers, ceramics or composite materials), as they have different properties that make 
them suitable for certain applications. To this concern one can differentiate between the 
bulk properties of the material (that govern the durability and its mechanical behavior) 
and the surface properties, which are the ones who really determine the biological 
response of the biomaterial. Here it must be introduced the term of biocompatibility: “the 
ability of a material to perform with an appropriate host response in a specific application” 
(Williams, 1987) [19]. 
According to the affirmation that surface properties are the ones responsible for the 
biological response (that is indeed the biocompatibility of a material) it becomes apparent 
that surface modification of a certain material can provide several advantages in the use 
of that given material. In particular, when this surface modification is performed for the 
material to have an enhanced biological property or function (that can be either permanent 
or temporary) this process is defined as biofunctionalization.  Surface modifications fall 
mainly in two categories: Physicochemical surface treatment and biological methods.  
The material selected in this work as a model of biomaterial is silicon, whose main 
biomedical applications are in the field of diagnosis and therapeutics (being used mainly 
for biosensors and bioimaging and in some cases for drug delivery, cancer therapy and 
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tissue engineering applications) [4][6][9]. However, it is expected that the 
biofunctionalization techniques explored in this work can be also applied also for other 
biomaterials with similar properties (like Titanium) that may have very different 
applications in the biomedical field. 
In many cases, biofunctionalization implies the binding of biomolecules to the surface 
(biological surface modification). The immobilization of the biomolecule can be 
performed with several techniques: physical adsorption, physical entrapment and 
covalent attachment, being the latter the most stable one. In the case of biosensors, 
proteins offer a wide range of possibilities thanks to its broad variety and flexibility, and 
several types of receptors can be built based on these proteins. It is worth-mentioning the 
application of AFM probe functionalization for detection of antibodies, receptors or other 
types of markers on the cell surface [20]. Some other relevant applications require 
biological surface modification motifs that consist of binding fibronectin RGD containing 
peptides to promote cell attachment, heparin and heparin sulfate binding peptides to 
enhance cell adhesion and growth factors to induce specific cell responses.  
“Crosslinking reagents (or crosslinkers) are molecules that contain two or more reactive 
ends capable of chemically attaching to specific functional groups (primary amines, 
sulfhydryls, etc.) on proteins or other molecules.” (Thermo Fisher Scientific,”Chemistry 
of Cross-linking”) [17]. Therefore they emerge as promising tools for bioconjugation of 
proteins. Depending on whether the two functional groups of the cross-linker are identical 
or different they can be classified in homobifunctional or heterobifuntional crosslinkers. 
On the other hand, if we classify them by the type of functional group they interact with, 
we find Primary Amine Reactive Cross-Linkers, Sulfhydryl Reactive Cross-Linkers, 
Carbohydrate Reactive Cross-Linkers, Carboxyl Reactive Cross-Linkers and 
Photoreactive Cross-Linking Reagents. The most widely used types of crosslinkers for 
protein immobilization are heterobifunctional crosslinkers that interact with proteins via 
amino or sulfhydryl groups, as these are numerous and readily available in peptide groups 
and cysteines. Within these sets of cross-linkers we can find different chemistries: 
 Primary Amine Reactive Cross-Linkers: Imidoesters and N-Hydroxysuccinimide-
Esters (NHS-Esters). Imidoesters leave amidine protonated bonds whereas NHS 
esters leave amide bonds. Since NHS esters are more stable and efficient they are 
more widely used.  
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 Sulfhydryl Reactive Cross-Linkers: Maleimides, Haloacetyls and Pyridyl 
disulfides. It must be noted that even though all of them attach to thiol groups, the 
only ones that leave a disulfide bond are pyridyl disulfides; Maleimides and 
haloacetyls leave tioether bonds. 
One main difference between each type of crosslinker is the pH at which the reaction 
takes place (and therefore the buffer that must be selected for each of them). Table 1 
presents a summary of the reaction mechanism of each type of crosslinker and the pH at 
which the reaction takes place. 
TABLE 1: REACTION MECHANISMS AND PH CONDITIONS FOR SOME TYPES OF 
CROSSLINKERS
 
*Adapted from [17] 
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For the use of these type of molecules on a solid surface, the surface needs to be 
previously functionalized with one of the aforementioned functional groups in order to 
be able to react with the protein. Therefore, the full biofunctionalization process would 
involve 3 steps: (1) existence of available  functional groups on the surface of the material, 
(2) reaction of the crosslinker with the functional group on the surface and, finally, (3) 
reaction between the crosslinker and the protein. (Figure 1) 
 
Figure 1: General scheme of a full 3-step biofunctionalization procedure. (Bauer et al, 2013) [18] 
More specifically, in this work the silicon thin film was biofunctionalized with amine 
groups using activated vapor silanization (AVS), which is a type of physicochemical 
surface treatment. Other methods for generating amine groups on metallic surfaces 
include immersion silanization and different types of plasma treatments. 
AVS is based on the chemical vapor deposition (CVD) technique in which vaporized 
APTS is deposited on the sample surface. Activation of the APTS molecules occurs at 
high temperatures (700ºC) and both activation and deposition of APTS on the surface 
takes place at low vacuum. This silanization technique has proven to produce thin films 
with a homogeneous distribution and high density of amine groups and to have more 
efficiency than other biofunctionalization techniques. [8] 
2.1.2. The importance of protein adsorption and its characterization 
Protein adsorption is the process whereby a protein is adhered onto a solid surface. It is 
the first event in blood-material interaction, affecting greatly blood coagulation, 
complement activation and bacterial and cell adhesion. These protein surface interactions 
will condition to a great extent the fate of the blood-biomaterial interface. From a 
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thermodynamic point of view, protein adsorption is favored if it reduces ∆G: 
ΔGadsorption = ΔGprotein + ΔGsolvent + ΔGsurface  
Before a protein can adhere to a substrate, it must be transported to its vicinity by different 
mechanisms (diffusion, convection and/or coupled transport). Afterwards, it undergoes 
conformational changes (known as molecular spreading) exposing functional groups 
ready to create new contacts with the surface and making desorption less likely. 
The protein adsorption process is highly dependent on the protein properties (size, 
hydrophobicity, charge and protein unfolding). Nevertheless surface properties are 
equally important (topological features, surface chemical composition and of course the 
presence of biofunctional motifs). [5][18] 
Being this process as vital as it is to determine the biocompatibility of the material, it was 
aimed to gain a better understanding of the process and conditions under which it takes 
place. In addition, the protein employed, lactate dehydrogenase (LDH) is intended to be 
used as model molecules to evaluate the efficiency of the whole biofunctionalization 
program. 
Currently there are several mathematical models that try to parametrize the protein 
adsorption phenomenon, each of which making different assumptions on transport 
processes and protein and surface properties.  
Figure 2 shows an overview of the main mathematical models currently used in research 
in this field. Some other approaches to model the kinetics of protein adsorption are with 
computational tools such as Monte-Carlo simulations, molecular dynamics simulations 
and energy optimization methods. [11] 
However theoretical models must be compared with the experimental reality to fit it to 
the conditions under study with label-free or fluorescence techniques. Several parameters 
used in this type of models are protein and/or surface dependent, as for example the 
diffusion coefficient, sticking coefficient, or on-rate and off-rate constants. Consequently 
there is a need of detailed characterization of the protein and surface and its interaction 
by experimental methods to fully understand protein adsorption in a given condition. 
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2.2. Design of solutions 
2.2.1. Background of cross linker 
chemistry 
The biomaterials group at CTB had 
already worked on protein 
immobilization on solid surfaces [2] 
[8][16]. However the techniques used 
were permanent. In an attempt of 
creating reversible protein 
functionalization, the disulfide bond 
between thiol groups emerged as a 
good possibility for exploring new 
biofunctionalized schemes, as this 
type of bond is strong (with a typical 
dissociation energy of 60kcal/mol), 
are naturally found between thiol 
groups in cysteines of proteins and is 
reversible by treating it with reducing 
agents as DTT. 
Keeping in mind the objective of 
forming disulfide bonds between the 
cross-linker and the protein of interest 
and having amine groups exposed on 
the surface of the biomaterial, the 
choices of crosslinker were narrowed 
as the two functional groups had been 
already set. Three different 
possibilities were found viable for the 
applications: 4-mercaptobutyric acid, 
4-mercaptophenylacetic acid and 
sulfosuccinimidyl 6-(3'-(2- pyridyldithio)propionamido)hexanoate (Sulfo LC-SPDP) 
(Figure 3). 
Figure 2:  Overview of the main models of protein adsorption. (M. Rabe 




Figure 3:  Chemical structure of crosslinkers to be studied 
 
For the attachment of both 4-mercaptobutyric and 4-mercaptophenylacetic acids the 
EDC/NHS reaction chemistry was selected as a way of adhering the molecule to the 
aminated surface. EDC is a carbodiimide (a type of carboxylic reactive crosslinker) that 
causes direct conjugation of carboxylic groups to amines. In the EDC reaction chemistry, 
an unstable intermediate (O-acylsourea) is formed. Adding NHS (or its water soluble 
analog (sulfo-NHS)) increases the efficiency of the reaction as the intermediate formed 
in this case (an NHS ester) is considerably more stable. In addition, EDC reaction occurs 
at acidic pH whereas when coupled to NHS, it allows the reaction to happen efficiently 
at physiological pH. Figure 4 shows the mechanism of EDC/NHS reaction chemistry.  
For the Sulfo LC-SPDP the reaction mechanism is shown in Figure 5. 
 
Figure 4:  EDC/NHS reaction chemistry. Carboxyl-to-amine crosslinking using the carbodiimide EDC and 
Sulfo-NHS. Addition of NHS or Sulfo-NHS to EDC reactions (bottom-most pathway) increases efficiency 




Figure 5:  Sulfo LC-SPDP reaction chemistry. In our application the agarose bead would represent the 
Silicon thin film. Instead of DADPA resin we would have a primary amine. 
 
One particular advantage of Sulfo LC-SPDP against the other two crosslinkers is that 
upon interaction with a thiol group, Pyridine-2-thione is released as a byproduct. This 
molecule has an absorbance peak at 343nm which would allow to add a simple checkpoint 
in the experiment to detect whether or not and to which extent the protein has been 
immobilized onto the surface. 




Figure 6:  Steps of biofunctionalization for each of the crosslinkers 
 
2.2.2. LDH as a protein model 
The protein used in this work is Lactate dehydrogenase (LDH). It is present in mammalian 
cell cytoplasm. Its function is to regenerate NAD+ from NADH and pyruvate in low-
oxygen conditions to keep glycolysis working. This protein has not been proven to have 
a beneficial effect regarding the compatibility of a material. However, it is a marker of 
cell death and tissue damage. Nevertheless, the main reason why this protein has been 
selected is because it is very easy to track its presence by means of spectrophotometry 
studies. Both NAD+ and NADH have absorbance peaks at 259nm but only NADH 
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exhibits another peak at 340nm (Figure 8). Therefore, as the reaction takes place and 
NAD+ is generated from NADH, a decrease in the absorbance at 340nm can be observed.  
 





3. MATERIALS AND METHODS 
3.1. Biofunctionalization of silicon thin films 
3.1.1. Crosslinking protocols in solution 
In order to test the binding of the different cross-linking agents to the amine groups on 
the surface of the AVS functionalized silicon films and to optimize the concentrations of 
each reagent, a model in solution was performed.  
This model would consist on a solution of Concanavalin A from Canavalia eusiformis 
saturated in amine groups. It was assumed that each Concanavalin molecule has 6 amines 
per molecule (one per arginine) available for binding to the cross-linker, as the 
constitutive amino group of each amino acid would be involved the peptide bond. A 1mM 
solution of Concanavalin A (that is, a 6mM solution of amine groups) was aimed for each 
of the cross-linkers. Since the different cross-linkers require different buffers and 
procedures, two different protocols were followed. 
For each cross-linker and concentration two different assays were performed to study the 
binding: 
 Functionalization of the protein followed by a dialysis 
 Functionalization of the protein, labelling with fluorescein 5-maleimide and 
finally dialysis. 
In both cases the absorbance of the sample was measured with a spectrophotometer both 
before and after dialysis at the following wavelengths:  
 280nm: to measure protein concentration (concentration of concanavalin) 
 343nm: absorbance of pyridine-2-thione (a byproduct of the reaction of Sulfo LC-
SPDP when reacting with a sulfhydryl group) 
 494nm: absorbance of fluorescein 5-maleimide 
The size of the pore of the dialysis membrane (3500 Da) was smaller than the size of 
concanavalin but significantly bigger than the size of all the cross-linkers and of 
fluorescein. Only the cross-linker bound to the protein would be retained inside the 
dialysis column, whereas the unreacted molecules would be eluted. In the fluorescence 
labelled case, the fluorescein would only attach to those concanavalin molecules that have 
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been successfully functionalized, as the maleimide group reacts with the thiol group that 
the cross-linkers leave exposed. (Figure 9) 
 
Figure 9:  Maleimide reaction chemistry. (R) represents a labeling reagent or one end of a crosslinker having 
the maleimide reactive group; (P) represents a protein or other molecule that contains the target functional 
group (i.e., sulfhydryl, -SH). (Crosslinking technical handbook. Thermo Scientific) 
 
3.1.1.1. Cross-linkers requiring EDC/NHS chemistry 
The buffer required for this reaction chemistry was MES buffer (0.1M MES hydrate in 
distilled water pH=3.74). Therefore the concanavalin solution was prepared in this 
solvent.  
On a first stage, two different concentrations of cross-linkers were tested (1X and 10X). 
The concentration 1X would have ten times of cross-linker molecules than amines, and 
for the 10X, a hundred times the amount of amines. The concentration for the 1X samples 
was 6x10-5 moles/mL and for the 10X samples, 6x10-4 moles/mL 
In the case of 4-mercaptophenyl acetic acid it had to be first dissolved in 0.25mL of 
ethanol and then transferred to the 0.25mL of the concanavalin in MES buffer solution as 
it had a very low solubility in MES buffer. 4-mercaptobutyric acid was directly dissolved 
in 0.25mL of MES buffer and then mixed with 0.25mL of concanavalin in MES buffer 
solution. 
In both cases, the amount of NHS was kept as the same amount of NHS than cross-linker, 
and the amount of EDC was four times larger than that of NHS (according to the literature, 
increasing the amount of EDC with respect to NHS stabilizes the reaction). 
For the functionalization of the concanavalin, the protein solution and the cross-linker 
solution were mixed and incubated for 1h. Then 1mL EDC/NHS solution was added and 
the incubation continued for 4 more hours at room temperature. Then the samples were 





3.1.1.2. Sulfo LC-SPDP  
In this case, the buffer required by this chemical according to the technical sheet of the 
product, was PBS-EDTA coupling buffer (50 mM Phosphate, 0.15 M NaCl, 10 mM 
EDTA, pH 7.2). The cross linker solution was prepared by mixing 50uL of a 10mM 
solution of Sulfo LC-SPDP in distilled water per mL of coupling buffer. It was then added 
to the protein solution and incubated for 30minutes minimum at room temperature to 
allow binding. Then the samples were separated for dialysis or fluorescence labelling. 
This was the only concentration tried for this reactant as it was the one indicated in the 
protocol of the supplier. 
3.1.1.3. Labelling with fluorescein 5-maleimide  
For the labelled assays, 1mg of fluorescein 5-maleimide was added to each 5mL sample 
that was then incubated overnight at 4ºC. 
3.1.2. Functionalization of Si thin films 
Silicon wafers were cut in 1cm2 square samples. They underwent a cleaning protocol 
consisting on sonication in acetone and isopropanol, treatment with hydrofluoric acid, 
piranha solution and ethanol and were dried with argon. Then they were amine-
functionalized in a 20-minute cycle in the AVS equipment.  
3.1.2.1. Activated vapor silanization (AVS) 
The silanization process was performed in a device designed and constructed entirely by 
the biomaterials group at Centro de Tecnología Biomédica (CTB-UPM) [7]. A scheme 
of the device is shown in Figure 10.  
Four silicon samples were placed in the AVS device holder that was then introduced in 
the chamber. 3mL of APTS were placed inside the evaporation chamber. The system was 
then closed and sealed. Then the vacuum pump was turned on. Once the pressure reached 
a value in the range of 10-2mbar, dry ice and acetone were poured into a cold trap. The 
activation furnace was then turned on to 750ºC and the temperature controller of the 
evaporation chamber was set to 150ºC. The argon tank valve controlling argon flux was 
opened and the pressure was adjusted to 1.9-2.1mbar. The duration of a functionalization 
cycle is 20 minutes. This cycle timing yields an approximate amine thickness layer of 
200nm. When the system had cooled down, the samples were taken out and allow to cool 
to room temperature. 
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Before further functionalization the samples were cleaned again by sonication in acetone 
and ethanol. 
 
Figure 10:  Scheme of an AVS reactor with each of its components. (1) Evaporation chamber, (2) 
Evaporation furnace, (3) Tape furnace, (4) Activation furnace, (5) Activation chamber. (Martin Palma et 
al., 2004) [7] 
 
3.1.2.2. Cross-linkers requiring EDC/NHS chemistry 
As it was aimed to replicate the conditions of the concanavalin-in-solution experiment, 
the same concentration of cross-linker (6x10-5 moles per mL), NHS (5X amount of 
crosslinker) and EDC (4X amount of NHS) was employed to prepare the crosslinker and 
EDC/NHS solutions for functionalization. These solutions were performed in MES buffer 
(0.1M, pH 3.74). 
The clean silicon samples were placed in a multi well, covered with 0.5mL of cross linker 
solution and incubated at room temperature for 1h. After that, 0.25mL of EDC/NHS 
solution were added to each sample well and incubated for 4 more hours.  
Once the functionalization was done, the samples were washed in MES buffer to 
eliminate non-reacted products and transferred to a new well. 
3.1.2.3. Sulfo LC-SPDP  
The clean silicon samples were placed in a multi well, covered with 0.5mL of an 
analogous Sufo LC-SPDP solution to the one used for the solution experiment prepared 
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(final concentration 0.5mM) and incubated for 30 minutes at room temperature. Then the 
samples were washed in distilled water and transferred to a new well.  
3.1.2.4. Labelling with fluorescein 5-maleimide 
To prepare the surface, each simple was incubated in 1mL of coupling buffer for 1h. 
Afterwards, coupling buffer was substituted by 1mL of fluorescein solution and incubated 
overnight at 4ºC. Then the samples were washed in coupling buffer and transferred to a 
new well. 
3.2. Study of the kinetics of protein adsorption on the surface 
Cleaning and preparation of the silicon surface for this experiment was found to be critical 
as the oxide layer on silicon films could interfere with the adsorption process of the 
protein. The cleaning protocol consisted again in sonication in acetone and isopropanol 
for 3 minutes, followed by a 10 minute bath in a 10% HF solution (for passivating the 
surface), a brief wash in piranha solution and a final wash in ethanol to be then dried with 
argon. Before every enzymatic assay the surface was equilibrated by a 1-hour incubation 
in Tris-HCl (0.1M, pH 7,1). 
3.2.1. Calibration curve of NADH 
As the amount of protein on the surface was to be derived from the amount of NADH 
consumed along time, measured as the change in absorbance at 340nm (peak of 
absorption of NADH), a calibration curve was needed to relate the absorbance measured 
in the spectrophotometer and the amount of NADH.  
By Lambert-Beer’s law it is known that it can be obtained an equation of the form: 
𝐴𝑏𝑠 = 𝑚 × [𝑁𝐴𝐷𝐻]    (Eq. 1) 
Where Abs is the absorbance measured in the spectrophotometer in a.u. and [NADH] is 
the concentration of NADH on the sample.  
A blank solution of Tris-HCl (0.1M, pH 7,1) with sodium pyruvate 2.9mM (the other 
necessary reactant for the LDH reaction) was prepared and used to set the 0.000 
absorbance in the spectrophotometer. From that blank solution a stock solution of NADH 
6mM was prepared to then obtain a set of more diluted solutions (0.05mM, 0.1mM, 
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0.2mM, 0.3mM and 0.4mM). The equipment used for this measurements was a Halo RB-
10 (Dynamica) spectrophotometer with a 1cm long quartz cuvette.  
A total of 5 measurements were taken for each concentration. After 3 measurements, the 
cuvette was washed with blank solution and the absorbance with blank solution was 
checked. In the cases where it was non-zero, the value was kept to correct the following 
two measurements. Before changing to a new concentration the cuvette was washed again 
and the blank-correction measurement was performed. The five absorbance values for 
each concentration were averaged to obtain the calibration curve. 
The slope of Eq.1 was obtained by least-squares fitting with Excel. 
The calibration curve was performed every week in order to ensure an accurate calibration 
according to the analyte as it could be degraded along time during storage.  
3.2.2. Enzymatic activity of LDH 
Another calibration experiment was needed to characterize the enzyme for further 
analysis of its adsorption on a solid substrate; the quantification of its enzymatic activity 
for the reaction: Pyruvate + NADHLactate + NAD+ 
We define the enzymatic activity of an enzyme as the amount of substrate converted per 
unit time per unit mass of the enzyme. 
In this case, a solution of 0.18mM of NADH and a 0.1ug/mL LDH solution were prepared 
and placed in the spectrophotometer cuvette. The absorbance was monitored during 10 
minutes by taking measurements every 30 seconds. The same process was performed with 
a solution of [LDH]=0.05ug/mL. 




×     Eq. 2 
Where U is the enzymatic activity in  
×




 can be obtained as the slope from a linear fitting of the measurements of 
absorbance of the experiment transformed to molar units using Eq. 1 and the value of the 
slope from the calibration curve of NADH. 
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3.2.3. Study of adsorption under static conditions 
As a first approach, the process of adsorption of a protein (in this case LDH) to a solid 
surface was studied under static conditions to see the dependence of the time of incubation 
and of the concentration of the protein on the adsorption process. This study would serve 
as control to compare it with the results under dynamic flow incubation conditions and to 
compare the adsorption of the protein on naked silicon versus functionalized silicon.  
For this study the silicon samples were cleaned following the cleaning protocol mentioned 
previously, placed in a multi-well and incubated for 1h in Tris-HCL (0.1M; pH 7.1) for 
one hour to equilibrate the surface prior to the beginning of the experiment. The 
concentrations of LDH to be compared were 50ug/mL, 80ug/mL, 110ug/mL and 
300ug/uL. For each sample, four different incubation times 30min, 60min, 120min and 
240min were studied. 
The corresponding LDH solution was prepared in Tris-HCl (0.1M, pH 7.1). Once the 
equilibration of the surface was done, the Tris-HCl buffer was removed and substituted 
by 600uL of LDH solution with the desired concentration and allowed to incubate at room 
temperature for 30, 60, 120 and 240min respectively. 
After the incubation time, the LDH solution was removed and the sample was washed in 
1mL of Tris-HCl (0.1M, pH 7.1) by carefully pipetting up and down against the wall of 
the well to remove the unadsorbed protein. Then it was transferred to a new well and 
covered with 600uL of stock NADH solution (6mM NADH in blank solution). The first 
spectrophotometry measurement (corresponding to time 0, i.e., starting conditions) was 
taken by transferring 30uL of solution from the well into the spectrophotometer cuvette 
containing 970uL of blank solution and measuring the absorbance at 340nm. The cuvette 
was inverted twice with a parafilm for proper mixing of the 30uL sample with the blank 
solution in the cuvette. The same measurement was performed every 30minutes for 90 
minutes. After every measurement the cuvette was washed with blank solution and a 
calibration measurement with blank solution was taken for calibration. 
In order to account for the reduction in volume in the sample well after each 30uL 
extraction, a correction of the Beer-Lambert Law from Eq 2. was made using Equation 3: 





)               Eq. 3 
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Where n corresponds to the number of previous samples taken (being n=0 for the time 0 
measurement), 𝑂𝐷  is the absorbance measured at 340 nm, 𝑉  is the volume inside 
the spectrophotometer cuvette (970uL+30uL=1mL), 𝑉  is the volume remaining in 
the sample well at time 𝑡  (that is, (600uL-30xn uL)), 𝑉  is the 30uL taken for each 
measurement, l is the length of the cuvette (1cm) and 𝜀 is the molar extinction coefficient 
in  
×
. In practice, the term 𝜀 × 𝑙 is replaced by the slope of the calibration curve of 
NADH for more accurate conditioning of the experiment.  
Knowing the NADH decay along time (which follows a linear relationship) and assuming 
that the enzymatic activity is the same in solution than when the enzyme is adsorbed on 
a substrate, the amount of adsorbed protein molecules can be extrapolated using Eq 2. 
Also, since the size of the silicon samples is kept constant at 1cm2 and knowing the molar 
mass of LDH (36595 Da) one can calculate the density of protein molecules adsorbed on 
the substrate.  
3.2.4. Study of adsorption under dynamic conditions 
As a more realistic model of the biological environment, another setting that allowed the 
flow of the LDH solution over the silicon substrate was prepared. The aim of this 
experiment was to observe how the volumetric flow rate (which in turn results in a shear 
strain rate) affects protein adsorption when compared to the static conditions described in 
the previous section.  
The experimental setting consisted on a pump connected to two plastic syringes (one for 
the inlet and another one for the outlet of the fluid) connected in turn to a metallic circular 
platform used normally as substrate holder in atomic force microscopy. The syringes and 
the platform were connected with plastic tubes. The silicon sample was stuck to the 
platform with vacuum grease. The platform with the sample was then covered with a petri 
dish to minimize evaporation of the protein solution during the process. A photograph of 
the experimental setting can be seen in Figure 11. 
Before the beginning of the experiment, the circuit was filled with protein solution 
avoiding as much as possible the formation of bubbles as these could hinder the 




Figure 11:  Set-up for the dynamic enzymatic study. Inlet and outlet syringes are connected to a syringe 
pump. The syringes are connected to the pool containing the silicon sample with plastic tubes. 
In view of the results obtained in the static conditions, it was decided that the optimal 
concentration to have a good time vs adsorption compromise was 110ug/mL. As a first 
approach, the experiment was performed with this concentration for different incubation 
times (30 and 60minutes) for a volumetric flow rate of 16.67uL/min. Then, also for a 
[LDH]=110ug/mL, the volumetric flow rate was halved (8.34uL/min). 
The cleaning and surface equilibration procedures were the same as for the static 
conditions experiment. Once the dynamic incubation was over, the sample was also 
treated similarly to the protocol followed for the static conditions study: It was washed, 
incubated with 600uL of NADH stock solution and spectrophotometry measurements 





4.1. Preliminary results of the crosslinking protocols in solution and optimization of the 
concentrations 
Both 10X concentrations were over saturated. They precipitated in the tube and formed 
granules. They were therefore discarded. 
The absorbance results for the concentrations 1X and Sulfo LC-SPDP can be observed in 
Tables 2 and 3. 
TABLE 2. ABSORBANCE (A.U.) OF THE UNLABELLED SAMPLES 
UNLABELLED 
4-MERCAPTOPHENYL 





BEFORE 3 1.305 3 
AFTER -0.102 0.274 0.101 
343NM 
BEFORE 3 1.305 3 
AFTER 0.119 0.078 0.023 
494NM 
BEFORE 1.223 0.013 2.387 
AFTER 0.068 0.053 0.017 
 
TABLE 3. ABSORBANCE (A.U.) OF THE LABELLED SAMPLES 
LABELLED 
4-MERCAPTOPHENYL 






BEFORE 3 1.818 3 
AFTER 3 0.816 3 
343NM 
BEFORE 2.097 2.854 0.518 
AFTER 3 0.484 1.231 
494NM 
BEFORE 1.353 0.516 2.854 




As another way of visualizing the results after functionalization and labeling, the labelled 
dialyzed samples were put in a multi well to be examined under a fluorescence 
microscope (Figure 12). 
 
Figure 12:  Fluorescence microscopy images of the labelled samples after dialysis 
Considering that the number of amines in solution was noticeably greater than that 
achievable in the 1cm2 silicon films, it was decided that the results obtained for 4-
mercaptophenyl acetic acid and 4-mercaptobutyric acid would not yield satisfactory 
results when applied in silicon films. The fraction of functionalized amines would be too 
low.  
Therefore the experiment was repeated changing the EDC and NHS concentrations. As 
the reaction follows a 1:1 stoichiometry for EDC, NHS and cross linker it was speculated 
that having a 1:1 proportion of NHS and cross linker was limiting the reaction. The new 
proportions proposed were 5X NHS than cross linker and 4X EDC than NHS (that is, 
20X EDC than cross linker). The protocol followed was maintained the same.  






















BEFORE 3 3 
AFTER 2.678 2.208 
343NM 
BEFORE 2.398 0.811 
AFTER 1.656 0.678 
494NM 
BEFORE 1.44 0.353 
AFTER 1.031 0.319 
 
TABLE 5. ABSORBANCE (A.U.) OF THE LABELLED SAMPLES FOR NEW EDC/NHS 
CONCENTRATIONS 
 
These new EDC/NHS concentrations were established as optimum and were the ones 










BEFORE 3 3 
AFTER 2.797 2.268 
343NM 
BEFORE 3 1.371 
AFTER 2.208 1.047 
494NM 
BEFORE 1.995 1.176 
AFTER 2.347 1.128 
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4.2. Functionalization of Si thin films 
After functionalization with the different cross-linkers, silicon samples were examined 
under the fluorescence microscope. The results of the functionalization can be seen as 
green fluorescence. Two negative controls were prepared for comparison: naked silicon 
and silicon treated with AVS but no further cross linking. In both cases they underwent 
the same cleaning and labeling protocols. Results can be observed in Figure 14.  
 
4.3. Study of the kinetics of protein adsorption on the surface 
4.3.1. Calibration curve of NADH 
An example of the data and the graphs obtained in a calibration curve experiment can be 
seen in Table 7 and Figures 15 and 16. As it can be observed, the variability in each of 
the measurements was negligible and, as expected, there was a linear relationship between 








TABLE 7: EXAMPLE OF THE DATA OBTAINED IN A CALIBRATION CURVE EXPERIMENT 
 0.05mM 0.1mM 0.2mM 0.3mM 0.4mM 
MEASUREMENT 1 0.369 0.982 1.288 2.078 2.994 
MEASUREMENT 2 0.37 0.986 1.288 2.078 2.994 
MEASUREMENT 3 0.371 0.984 1.288 2.078 2.994 
BLANK SOLUTION -0.001 -0.001 -0.002 0 0.005 
MEASUREMENT 4 0.371 0.971 1.287 2.076 2.995 
MEASUREMENT 5 0.371 0.973 1.291 2.076 2.995 
BLANK SOLUTION -0.003 0.001 -0.002 0.006  
ARITHMETIC MEAN OF CORRECTED 
VALUES 
0.3704 0.9792 1.2884 2.0772 2.9944 
 
 
Figure 15:  Example of a calibration curve for absorbance vs [NADH]. The five measurements for each 




Figure 16:  Example of a calibration curve for absorbance vs [NADH]. The mean of the five measurements 
and its linear estimation is shown. 
 
4.3.2. Enzymatic activity of LDH 
An example of the graphs obtained from the enzymatic activity experiment and used for 
the calculation of the enzymatic activity of LDH is shown in Figure 17. 
 
Figure 17:  Example of a calibration experiment for enzymatic activity of LDH. Only the linear region is 
shown as it is the one considered for the calculations. 
The amount of NADH due to the activity of the enzyme follows an exponential decay, so 
only the linear region of the experiment was considered for the linear fitting (which was 
usually the first 6 to 8 minutes of the experiment). 
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The value obtained in this particular case by averaging the activities obtained with the 
data of both LDH concentrations was 169.7 
×
. The theoretical range of enzymatic 
activity for this enzyme is between 117.3 and 225.2 
×
, so the value obtained (as it 
was the case in every repetition of the experiment) falls within these theoretical values. 
This test was performed periodically to check the possible degradation of the enzyme 
upon storage.  
4.3.3. Study of adsorption under static conditions 
Figures 16 and 17 show examples of the information obtained from the enzymatic assays. 
After several repetitions it was observed that the experiment was highly variable, as there 
was always a set of data points that diverged from the expected results. These deviations 
were random, not being related to a particular concentration or incubation time. It was 
therefore concluded that it was the consequence of experimental mistakes in the relatively 
sophisticated experimental procedure. When the experimental errors were removed, the 
tendency was clearly observed during the several repetitions of the experiment; The 
longer the incubation time, the more protein adsorbed on the substrate and therefore 
steeper a decay of NADH was observed (Figure 18); and the higher the protein 
concentration, the better the adsorption for the same incubation time (Figure 19).  
 




Figure 19:  Enzymatic assay in silicon for a fix incubation time (30min) and different concentrations of 
LDH 
4.3.4. Study of adsorption under dynamic conditions 
The results obtained for the dynamic conditions show no evidence of adsorption on the 
substrate neither for longer incubation times nor for slower volumetric flow rates. As it 
can be seen in Figure 20, there is not a linear decay of NADH as it was the case under 
static conditions. It was concluded that there was no LDH adsorbed on the silicon 
substrate and that the slight variability of the absorbance was due to experimental errors.  
 
Figure 20:  Enzymatic assay in silicon in dynamic conditions for a fix [LDH]=110ug/uL and two different 
incubation times (30min and 60min). Two repetitions of each incubation time were performed. 
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In order to guide the experimental procedure, a mathematical model was evaluated to see 
if the range of volumetric flow rates chosen for the experiment were appropriate to allow 
protein deposition. 
4.3.4.1. Mathematical model of adsorption in dynamic conditions 
In order to provide a better understanding of how the system of protein adsorption under 
dynamic conditions was working, a mathematical model describing the condition was 
elaborated. The model was adapted from the one proposed by Ortega-Vinuesa et al. [10] 
where they compare the process of protein adsorption of blood proteins in static versus 
dynamic conditions, with different shear rates. They concluded that the parameter that 
most affected the protein adsorption process was the concentration of the protein, whereas 
shear rate had almost no effect. Only a slight difference was observed between the 
completely static conditions and the dynamic conditions. They claimed that while in static 
conditions the only phenomenon acting is diffusion, when they introduced a fluid 
velocity, convection also starts to play a role. They define two different cases: 
 Diffusion limited adsorption: The rate of transport of the protein to the surface is 
slower than the rate of adsorption of the protein to the surface. This would occur 
mainly for low shear rates and more diluted solutions. 
 Kinetic limited adsorption: It is the opposite case; when the rate of transport of 
the protein to the surface is faster than the rate of protein adsorption. Mainly 
applies for faster shear rates or highly concentrated protein solutions.  
The adsorbed amount of protein will vary between both cases. 
It is reported in the bibliography that there are two key parameters that affect the system 
and are specific of each protein and for each buffer and surface; those are the sticking 
coefficient and the diffusion coefficient. These specific values can be extrapolated from 
the experimental results in under static conditions following a mathematical model based 
on experimental data published by Daniel R. Weaver and William G. Pitt [12].  
They elaborated a graph that relates the dimensionless observed slope of protein 
adsorption over time (which can be obtained from the enzymatic assays for different 
incubation times for the same concentration. See results section) with the dimensionless 
reaction rate. Once the dimensionless reaction rate is calculated, the sticking coefficient 
can be easily obtained for our specific condition following Equation 4. The experimental 
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slope obtained in the experiments can be transformed into the dimensionless observed 
slope using Equation 7. 
          Φ =
× × ×
×
   Eq. 4  
Where q is the probability of a step from the outlet towards the surface due to random 
walk (which is set to 0,5), P is the sticking coefficient, va is the average velocity of random 
walk in cm/s, Cm is the concentration of a monolayer in mg/cm2, D is the diffusion 
coefficient of our protein (LDH) for our specific surface (silicon) in cm2/s and Cb is the 
initial bulk protein concentration in mg/cm3.  
As we performed all the dynamic conditioned experiments with an LDH solution of 
[LDH]=110ug/mL, Cb is set to 0.11 mg/cm3. Cm was calculated using data obtained from 
previous experiments of LDH adsorption in silicon films using atomic force microscopy 
[1], where it was estimated that the diameter of an adsorbed LDH molecule (after the 
well-known flattening of the protein in contact with the surface) was 2.19nm. Assuming 
that the area a molecule of LDH occupies is of a round shape, it was found that the 
maximum concentration of a monolayer is 1.6x10-6 mg/cm2. va  is calculated using 
Equation 5. 
𝑣 =     Eq. 5 
Being k the Boltzmann constant in erg/moleculexKelvin (1.381x10-16), T is the absolute 
temperature in Kelvin (assuming room temperature, T=298) and Mw is the molecular 
weight of the protein in gr/molecule (6.1x10-20). The obtained value for va was 822.8 
cm/sec.  
For the calculation of the diffusion coefficient (D) it is assumed that a LDH molecule is 
spherical and therefore the Stokes-Einstein relation can be applied (Equation 6).  
𝐷 =       Eq. 6 
With k=Boltzmann constant in J/K (k=1.38x10-23), η the dynamic viscosity of the buffer 
at the temperature at which the experiment took place in kg/m*s (assuming the viscosity 
of water at room temperature gives a value of 0.008921) and rsol is the radius of the 
molecule in solution in m (extracted from the PDB, rsol=4.35x10-9). 
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For the dimensionless observed slope: 
Q =
√
     Eq. 7 
Where  is obtained from the enzymatic assays in silicon for the different incubation 
times.  
In accordance with the model by Ortega-Vinuesa et al. [10], if we find that in our system 
≪  it will mean that it is diffusion limited, whereas if we find that ≫  it will be 
kinetic limited. Here L is defined as the distance of the boundary layer to the surface and 
was calculated with Equation 8. 
𝐿 =     Eq. 8  
Being z the distance from the inlet and γw the shear rate at the surface. For pipe flow this 
is calculated with Equation 9, where X is the volumetric flow rate in L/s and R is the 
radius of the pipe in cm. 
𝛾 =       Eq. 9 
Once having identified if the system is diffusion limited or kinetic limited, one can 
calculate the adsorbed amount of protein for a given time in each case. 
For a diffusion limited system: 
Γ = 2𝐶     Eq.10 
And for a kinetic-limited system: 
Γ = 𝐶 𝑡    Eq.11 
The graph from which the dimensionless reaction rate (Φ) was to be obtained from the 
experimentally obtained value of the dimensionless observed slope (Q) extracted from 




Figure 21:  Dimensionless reaction rate (Φ) as a function of the dimensionless observed slope (Q). (Weaver 
and Pitt) [12] 
However the final value obtained for Q from the experiments in static conditions with 
[LDH]=110ug/mL was Q=4.37x10-3. Given the scale of the graph it was impossible to 
provide an estimate for Φ and therefore to obtain the sticking coefficient (P) for our 
specific condition. Weaver and Pitt assert in their paper that the difference between a 
system with Φ=1 and one with Φ=2x10-5 cannot be discerned with experimental data [12].  
The value obtained for the diffusion coefficient (D) was D=5.62x10-7 cm2/s which is in 
the range of the values used by Ortega-Vinuesa et al [10] to generate their results 
(Albumin (6.7x10-7) and fibrinogen (2x10-7)), and also in the range that Weaver and Pitt 
take as a typical value for a protein system (≈2.5x10-7) [12]. 
A comparison of the different values studied by Ortega-Vinuesa et al [10] for Albumin 
and Fibrinogen and the ones obtained in this work for LDH are presented in Table 8. 
It can be observed that the shear rates that have been tested in this work are considerably 
lower and the protein solutions noticeably more diluted, which would be in principle in 
accordance with a diffusion limited system. The limiting case between kinetic and 
diffusion limited adsorption for our system ( = ) occurs for P=1.99x10-6 for γw=2.83, 




TABLE 8: SOME PARAMETERS FOR THEORETICAL CALCULATION AND 




















225 6.7x10-7 10 12.8 5.2x10-6 2.5x10-6 2.5x10-8 
Fibrinogen 
(0.3mg/mL)* 
225 2x10-7 4 8.6 2.3x10-6 2.5x10-6 2.5x10-8 




















*Data extracted from Ortega-Vinuesa et al. [10] 
 
However, taking into account that it was impossible to determine Φ due to a too low value 
of Q that would in turn give a very low value of Φ (which is directly proportional to P), 
and considering that no adsorption was observed for the dynamic conditions, it was 
concluded that P<<3.94x10-7. If that was the case, then the adsorption of LDH on silicon 
in this conditions would be kinetic-limited, and the absence of adsorption could be 
explained by an unbalance between the rate of transport of the protein to the surface and 
the rate of adsorption of LDH to the surface. It is also worth mentioning that the 
incubation times for adsorption studies found in the bibliography are considerably lower 
than the ones proposed in this work, which can lead to thinking that the affinity of this 







5.1. Objectives accomplished 
In view of the successful results obtained using 4-mercaptobutyric acid, 4-
mercaptophenylacetic acid and Sulfo-LCSP it was concluded that they are good 
possibilities for crosslinking of proteins onto aminated surfaces in a reversible fashion by 
the use of disulfide bonds. The conjugation can also be applied in solution if the 
application requires so. Optimum conditions for the biofunctionalization reaction have 
been explained in this work along with the advantages that each of the molecules provide.  
It has been checked that protein adsorption (specifically of LDH) takes place under static 
conditions in bare silicon films and it is dependent on the incubation time and the 
concentration of the protein. However, no adsorption was observed when the conditions 
were dynamic. A mathematical model was used to understand the system workflow and 
estimations for the sticking coefficient and diffusion coefficient were obtained. By 
comparing these values and other experimental parameters with the ones used by different 
authors in the bibliography, it was concluded that either the experimental set-up and 
selection of the parameters was not suitable for the reaction to take place, or the affinity 
of LDH for silicon films was too low to detect adsorption at such low concentrations. On 
the other hand, since the enzymatic assays were very experiment-dependent due to its 
sensitivity to contamination, inaccurate measurements of the low amount of reactants or 
timing of the experiment, and the low number of repetitions of the experiment, it could 
have been a consequence of experimental error.   
5.2. Future lines of work 
The conjugation of protein to the surface as the final step of the initially proposed 
biofunctionalization procedure was not carried out due to lack of time, so as future work 
this should be finished to obtain as a final product a fully biofunctionalized silicon thin 
film able to interact with proteins in the environment. Enzymatic assays would have to be 
performed on these biofunctionalized silicon thin films and compared to the ones from 




Then, the reversibility and repeatability of disulfide bond formation between the protein 
and the surface in a stable and efficient manner should be proven. 
For the study in dynamic conditions, more repetitions of the experiment would be 
necessary to unveil if the non-adsorption in dynamic conditions is the product of 
experimental error. If that is not the case, concentration of the protein should be increased 
and faster shear rates should be introduced in the protocol. It would be interesting to find 
a set up such that the sticking coefficient could be determined to introduce it into the 
model. Some other proteins that have reported results in the literature, like albumin or 





6. SOCIO-ECONOMIC FRAMEWORK 
6.1. Budget 
On the following tables (Tables 9, 10, 11 & 12) it is presented the cost of each of the 
materials used throughout the project in order to get an estimate of its overall cost. 
Nevertheless, during the five months the project has lasted, not the full vial nor equipment 
packs were finished, so this data serves just as a rough approximation.  







Sigma Aldrich 510 12.5KU L1006- 
Sodium pyruvate Sigma Aldrich 14 5g P2256 
NADH Sigma Aldrich 136 500mg N8129 
Sulfo-LC-SPDP Sigma Aldrich 579,59 50mg 803316 
Silicon wafers Institute of electronic 
materials technology 
400 25uds S13949 
Concanavalin A Sigma Aldrich 115 100mg L7647 
4-mercaptobutyric acid Sigma Aldrich 60 100mg CDS004545 
4-mercaptophenylacetic 
acid 
Sigma Aldrich 63,9 1g 653152 
EDC Sigma Aldrich 127 5g E7750 





194 25mg 62245 





TABLE 10: COST OF LABORATORY MATERIAL 
MATERIAL AMOUNT COST (€) 
Pipette tips (big) Pack 1000 30,25 
Pipette tips (medium) Pack 1000 9,85 
Pipette tips (small) Pack 1000 21,8 
Falcon tubes 15ml Pack 500 392 
Multiwell plates Pack 75 157 
Dyalysis membrane 1x30.5m 197,98 
Gloves Pack 100 22,5 
Syringes 100uds 5,4 
 
TABLE 11: COST OF EQUIPMENT 
EQUIPMENT COST 
Dynamica Halo RB-10 Spectrophotometer Already amortized 
Fluorescence microscope Already amortized 
Computer Already amortized 
Power supply 118 
Pump Already amortized 
Digital Sonifier 450 Already amortized 
 
TABLE 12: COST OF HUMAN RESOURCES 
CATEGORY COST OF HUMAN PER MONTH (€) 
Laboratory technician 1150 
Bioengineering student 1000 
45 
 
6.2. Legal framework 
Before reaching the market or a final application in living cells, tissues or organisms, a 
medical device must comply with a certain set of standards and regulations. Being 
biocompatibility a necessary requirement for not damaging the living environment the 
device interacts with nor for eliciting undesired responses in the patient (including 
possible side effects or the release of hazardous byproducts), many of these regulations 
demand biocompatibility and characterization tests in the first steps. Of course, depending 
on the final application (implants, tissue engineering, laboratory material…) the tests to 
be underwent and its level of demand will vary. 
The ISO standard regulating biomedical devices is the ISO-10993 (Biological and 
Clinical Evaluation of Medical Devices) and the main tests regarding material 
biocompatibility, characterization and degradation products are [23]:  
o Part 4: Selection of tests for interactions with blood 
o Part 6: Tests for local effects after implantation 
o Parts 13, 14 & 15: Identification and quantification of degradation products 
o Part 18: Chemical characterization of materials 
o Part 19: Physico-chemical, morphological and topographical characterization of 
materials 
Another important international regulatory agency is ASTM. Some of its most general 
standards for new biomaterials and their interactions with the living world are ASTM 
F748 - 16 (Standard Practice for Selecting Generic Biological Test Methods for Materials 
and Devices) and ASTM F813 - 07(2012) (Standard Practice for Direct Contact Cell 
Culture Evaluation of Materials for Medical Devices). Nevertheless there are more 
precise standards depending on the final application. [22] 
6.3. Socio-economic impact 
The aim of this work is to contribute to develop a new biofunctionalization technique that 
can have several applications in the biomedical industry providing as a novelty an easily 
reversible protein cross-linking system. In addition, it intends to contribute to understand 
the protein adsorption process, a key factor on biomaterial outcome and its interactions 
with the living world.  
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All the medical equipment and devices must comply with the ISO10993 standard for FDA 
approval consisting on several biocompatibility tests, as rejection can have serious 
consequences on the patient in whom the biomaterial is being used. Regarding the 
diagnostics applications low biocompatibility can turn into biased and low quality results 
or difficulties during experimental practice.  
Such is the case that in the last 25 years there has been a skyrocketing increase in the 
number of papers citing the term “Biocompatibility” in their keywords (Figure 22). This 
trend is exhibited not only at a worldwide scale but also specifically in Spain (Figure 23).  
 
Figure 22:  Number of papers published regarding the term "biocompatibility" worldwide in the last 25 
years. (Data extracted from the Web of Science Citation Reports) 
 
Figure 23:  Number of papers published regarding the term "biocompatibility" in Spain in the last 25 years. 
The last point corresponds to data from May 2019, so it is expected to be at least doubled by the end of the 
year.  (Data extracted from the Web of Science Citation Reports) 
Therefore it can be concluded that this work is of scientific relevance as it provides an 
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